Export

EN
FR
Dolutegravir + lamivudine + tenofovir
Essential medicine status
General description

INN
Dolutegravir + lamivudine + tenofovir
ATC codes
J05AR27
Medicine type
Chemical agent
EML status history
Wikipedia
Dolutegravir + lamivudine + tenofovir
DrugBank
Dolutegravir ,
Lamivudine ,
Tenofovir (Tenofovir disoproxil)
Recommendations
Section
Fixed-dose combinations of antiretrovirals
  • Oral > Solid: 50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil)
Indications
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified